Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (PINL:NVIVQ)

InVivo Therapeutics Appoints Christopher McNulty as Chief Financial Officer

Business Wire March 29, 2017

InVivo Therapeutics Announces Seventh Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™

Business Wire March 28, 2017

InVivo Therapeutics to Present at Needham and Company’s 16th Annual Healthcare Conference

Business Wire March 27, 2017

InVivo to Initiate Cervical Spinal Cord Injury Study

Business Wire March 23, 2017

InVivo Therapeutics Announces Submission to the FDA of Its Nonclinical Studies Module for the Neuro-Spinal Scaffold™

Business Wire March 21, 2017

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Business Wire March 20, 2017

InVivo Therapeutics Receives Clinical Trial Application Approval from UK's Medicines Healthcare Products Regulatory Agency

Business Wire March 15, 2017

InVivo Therapeutics Reports 2016 Year-end Financial Results and Business Update

Business Wire March 10, 2017

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at Keck Hospital, University of Southern California

Business Wire March 9, 2017

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating InVivo Therapeutics Holdings Corp. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire March 8, 2017

InVivo Therapeutics to Present and Exhibit at Spine Summit 2017

Business Wire February 28, 2017

InVivo Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference

Business Wire February 27, 2017

InVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference

Business Wire February 7, 2017

InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™

Business Wire January 24, 2017

InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study

Business Wire January 19, 2017

InVivo Therapeutics Featured in Nationally Syndicated Radio Segment

Business Wire January 18, 2017

InVivo Therapeutics Announces University of New Mexico Hospital as New Site for INSPIRE Study

Business Wire January 17, 2017

InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital

Business Wire January 10, 2017

InVivo Therapeutics Announces St. Michael’s Hospital as New Canadian Site for INSPIRE Study

Business Wire January 9, 2017

InVivo Therapeutics Responds to PixarBio Announcement

Business Wire January 3, 2017